Ann: Notice of Annual General Meeting/Proxy Form, page-20

look at the balance sheet

its skewed imo

they apply more value to Karibib than to LPDs actual chemical tech IP

this again provides more credibility to my hypothesis that there is hostile inside influence and that CL or someone else is going to take a cheap stab at LPD tech without Karibib

interesting developments

again the sustainability report throws me totally off my thoughts

Joe doesn’t seem to be the pushover type